Johnson & Johnson will acquire robotic startup Auris Health for $3.4bn in cash, plus milestones payments of up to $2.4bn. Auris developed the FDA-cleared Monarch platform, which is expected to rival Intuitive Surgical's robotic-assisted bronchoscope device, Ion, awaiting FDA clearance.
Johnson & Johnson announced today it will acquire robotic startup Auris Health Inc. for $3.4bn in cash, plus milestones up to $2.4bn.
The companies have an existing partnership dating back to May 2018 to integrate J&J's Neuwave microwave ablation technology